GENZYME DEVELOPMENT PARTNERS L P
10-Q, EX-27.FDS, 2000-08-14
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: GENZYME DEVELOPMENT PARTNERS L P, 10-Q, 2000-08-14
Next: GEHL CO, 10-Q, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED FINANCIAL STATEMENTS OF GENZYME DEVELOPMENT PARTNERS, L.P. FOR THE SIX
MONTHS ENDED JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<EXCHANGE-RATE>                                      1
<CASH>                                             137
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                   198
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                     198
<CURRENT-LIABILITIES>                              226
<BONDS>                                              0
                                0
                                          0
<COMMON>                                             0
<OTHER-SE>                                        (26)
<TOTAL-LIABILITY-AND-EQUITY>                       198
<SALES>                                              0
<TOTAL-REVENUES>                                   122
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                    52
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                     72
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                 72
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                        72<F1>
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0
<FN>
<F1>GENZYME DEVELOPMENT PARTNERS, L.P. IS A DELAWARE LIMITED PARTNERSHIP. NET
EARNINGS OR LOSS ARE REPORTED PER PARTNERSHIP UNIT INSTEAD OF PER SHARE. THE
PARTNERSHIP RECORDED NET INCOME OF $72,000 IN THE SIX MONTHS ENDED JUNE 30,
2000 WHICH WAS ALLOCATED 1% TO THE GENERAL PARTNER AND 99% TO THE LIMITED
PARTNERS.
</FN>


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission